Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Queensland Health
US Army
Fish and Richardson

Generated: September 24, 2017

DrugPatentWatch Database Preview

FIORINAL Drug Profile

« Back to Dashboard

What is the patent landscape for Fiorinal, and when can generic versions of Fiorinal launch?

Fiorinal is a drug marketed by Allergan Sales Llc and is included in two NDAs.

The generic ingredient in FIORINAL is aspirin; butalbital; caffeine; codeine phosphate. There are twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine; codeine phosphate profile page.

Summary for Tradename: FIORINAL

Suppliers / Packagers: see list4
Bulk Api Vendors: see list62
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FIORINAL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc
aspirin; butalbital; caffeine
CAPSULE;ORAL017534-005Apr 16, 1986AARXYesYes► Subscribe► Subscribe► Subscribe
Allergan Sales Llc
aspirin; butalbital; caffeine
TABLET;ORAL017534-003Apr 16, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Allergan Sales Llc
aspirin; butalbital; caffeine; codeine phosphate
CAPSULE;ORAL019429-003Oct 26, 1990ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus